Bitcoin’s Recent Performance: A Market Overview

Let’s dive in and explore the factors contributing to Bitcoin's recent downturn, the broader impact on the crypto market, and what investors might expect from the digital asset in the coming weeks.

Why Bryant Riley's Buyout Bid Could Be The Only Option For B. Riley Financial

B. Riley Financial, once a stalwart in the financial services sector, has been grappling with a series of debilitating challenges that have significantly eroded its market value.

AST SpaceMobile: Could This Space-Based Cellular Broadband Pioneer Be the Next Big Thing?

AST SpaceMobile has recently been in the news after its stock price has appreciated by a staggering 800% over the past 6 months as the company is at the forefront of a groundbreaking venture to provide global cellular broadband directly from space.

Stock Market Today: Stocks Gain as Investors Await Fed Speech

Today, U.S. stocks are trading higher, with the S&P 500, Dow Jones, and Nasdaq each up about 0.5%. If these gains hold, the S&P 500 could achieve its longest winning streak since last November. This positive start to the week shows growing investor optimism ahead of Fed Chair Jerome Powell's upco...

Stock Market Today: Stocks Stage Comeback After Positive Labor Market Data

The major U.S. indices reversed course on Thursday, clawing back from recent losses after positive labor market data calmed investor anxieties. As of midday trading, the S&P 500 was up 1.92%, while the Nasdaq surged 2.32%, and the Dow Jones Industrial Average climbed to 1.43%.

Stock Market Today: Market Moves Higher as Investors Digest CPI Report, Eyeing Fed Policy

U.S. stocks are showing mixed movement this Wednesday as investors grapple with the results of the latest Consumer Price Index (CPI) report. The S&P 500 was up a modest 0.15%, while the tech-heavy Nasdaq Composite was down 0.2%. The Dow Jones Industrial Average is faring the best, climbing 0.4%

Embecta’s Bold Move: Will This Insulin Needle Giant Be the Next Big Acquisition Target?

Embecta, a renowned producer of disposable insulin pen needles and syringes for diabetics, has initiated steps to explore a potential sale after a challenging period where its shares plummeted nearly 70% since its spin-off from Beckton Dickinson.
You've successfully subscribed to WallSt Focus
Great! Next, complete checkout for full access to WallSt Focus
Welcome back! You've successfully signed in.
Unable to sign you in. Please try again.
Success! Your account is fully activated, you now have access to all content.
Error! Stripe checkout failed.
Success! Your billing info is updated.
Error! Billing info update failed.